On 23 November, 2 separate firms published articles about a Special Alert issued in the US warning that speaker programmes organized by pharmaceutical and medical device companies pose inherent fraud and abuse risks.  The “speaker programs” in question are defined as company-sponsored events at which a health care professional makes a speech or presentation to other health care professionals about a drug or device product or a disease state on behalf of the company.  In these scenarios, the company generally pays the health care professional speaker and provides remuneration (such as free meals) to the attendees.  In the last 3 years, drug and device companies have reported paying nearly $2 billion to health care providers for speaker-related services.

I had omitted the following link (as it did not seem to generate much interest!), but it seemed time to add it again and say that, if you would like to make a (polite) gesture and help me with my removal and computer costs, I have a page at

Author: raytodd2017

Chartered Legal Executive and former senior manager with Isle of Man Customs and Excise, where I was (amongst other things) Sanctions Officer (for UN/EU sanctions), Export Licensing Officer and Manager of the Legal-Library & Collectorate Support Section

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: